company background image
ALBERTDAVD

Albert David NSEI:ALBERTDAVD Stock Report

Last Price

₹550.15

Market Cap

₹3.1b

7D

2.1%

1Y

-18.7%

Updated

03 Feb, 2023

Data

Company Financials

ALBERTDAVD Stock Overview

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India.

ALBERTDAVD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends6/6

My Notes

New

Notes are coming soon

Albert David Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Albert David
Historical stock prices
Current Share Price₹550.15
52 Week High₹727.40
52 Week Low₹486.85
Beta0.23
1 Month Change-3.46%
3 Month Change-8.35%
1 Year Change-18.67%
3 Year Change8.34%
5 Year Change43.98%
Change since IPO76.19%

Recent News & Updates

Recent updates

Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching

Feb 14
Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now

Sep 08
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now

Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)

Feb 06
Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)

Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?

Jan 22
Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?

Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters

Jan 07
Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters

Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?

Dec 23
Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?

Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative

Dec 08
Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative

Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)

Nov 23
Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)

A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)

Nov 08
A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)

Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Oct 13
Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?

Sep 28
Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?

What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?

Sep 13
What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?

Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?

Aug 28
Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?

Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?

Aug 10
Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?

A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)

Aug 10
A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)

Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks

Jul 20
Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks

Shareholder Returns

ALBERTDAVDIN PharmaceuticalsIN Market
7D2.1%-1.2%-1.1%
1Y-18.7%-8.1%-3.4%

Return vs Industry: ALBERTDAVD underperformed the Indian Pharmaceuticals industry which returned -8.7% over the past year.

Return vs Market: ALBERTDAVD underperformed the Indian Market which returned -4.1% over the past year.

Price Volatility

Is ALBERTDAVD's price volatile compared to industry and market?
ALBERTDAVD volatility
ALBERTDAVD Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.4%

Stable Share Price: ALBERTDAVD is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ALBERTDAVD's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19381,326n/ahttps://www.albertdavidindia.com

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries.

Albert David Limited Fundamentals Summary

How do Albert David's earnings and revenue compare to its market cap?
ALBERTDAVD fundamental statistics
Market Cap₹3.14b
Earnings (TTM)₹340.34m
Revenue (TTM)₹3.32b

9.2x

P/E Ratio

0.9x

P/S Ratio

Is ALBERTDAVD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
ALBERTDAVD income statement (TTM)
Revenue₹3.32b
Cost of Revenue₹1.21b
Gross Profit₹2.10b
Other Expenses₹1.76b
Earnings₹340.34m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)59.63
Gross Margin63.42%
Net Profit Margin10.26%
Debt/Equity Ratio0%

How did ALBERTDAVD perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

15%

Payout Ratio